Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:28 pm Purchase | 2025-06-30 | 13G | Edgewise Therapeutics, Inc. EWTX | BAKER BROS. ADVISORS LP | 7,305,940 6.900% | 1,465,881 (+25.10%) | Filing History |
| 2025-08-14 4:25 pm Sale | 2025-06-30 | 13G | Edgewise Therapeutics, Inc. EWTX | Perceptive Advisors LLC | 4,639,949 4.400% | -1,755,597 (-27.45%) | Filing History |
| 2025-08-14 11:44 am Purchase | 2025-06-30 | 13G | Edgewise Therapeutics, Inc. EWTX | JANUS HENDERSON GROUP PLC JHG | 5,503,349 5.200% | 221,195 (+4.19%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Edgewise Therapeutics, Inc. EWTX | BlackRock Inc. BLK | 5,824,866 5.500% | -568,701 (-8.89%) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Perceptive Advisors LLC | 6,395,546 6.100% | 1,231,059 (+23.84%) | Filing History |
| 2025-05-14 12:29 pm Purchase | 2025-03-31 | 13G | Edgewise Therapeutics, Inc. EWTX | JANUS HENDERSON GROUP PLC JHG | 5,282,154 5.600% | 298,214 (+5.98%) | Filing History |
| 2025-05-12 7:13 pm Purchase | 2025-05-09 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 15,252,867 14.500% | 496,771 (+3.37%) | Filing History |
| 2025-02-21 5:57 pm Purchase | 2025-02-13 | 13G | Edgewise Therapeutics, Inc. EWTX | Perceptive Advisors LLC | 5,164,487 5.500% | 5,164,487 (New Position) | Filing History |
| 2025-02-14 11:24 am Purchase | 2024-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | JANUS HENDERSON GROUP PLC JHG | 4,983,940 5.300% | 4,983,940 (New Position) | Filing History |
| 2025-02-03 4:36 pm Purchase | 2025-01-27 | 13G | Edgewise Therapeutics, Inc. EWTX | Paradigm BioCapital Advisors LP | 4,738,929 5.000% | 4,738,929 (New Position) | Filing History |
| 2024-11-14 6:22 pm Sale | 2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | EcoR1 Capital, LLC | 1,250,385 1.300% | -2,242,809 (-64.21%) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | VIKING GLOBAL INVESTORS LP | 1,481,146 1.600% | -4,678,000 (-75.95%) | Filing History |
| 2024-11-14 4:14 pm Purchase | 2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | BAKER BROS. ADVISORS LP | 5,840,059 6.200% | 5,840,059 (New Position) | Filing History |
| 2024-11-14 08:59 am Sale | 2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | Deerfield Mgmt, L.P. | 1,781,006 1.900% | -2,697,586 (-60.23%) | Filing History |
| 2024-11-12 5:23 pm Unchanged | 2024-11-07 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 14,756,096 15.600% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:55 am Sale | 2024-11-08 | 13G | Edgewise Therapeutics, Inc. EWTX | FMR LLC | 653,207 0.696% | -4,127,355 (-86.34%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | BlackRock Inc. BLK | 6,393,567 6.800% | 0 (Unchanged) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | BlackRock Inc. BLK | 6,393,567 6.800% | 2,888,368 (+82.40%) | Filing History |
| 2024-09-23 9:20 pm Sale | 2024-09-19 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 5,549,900 5.900% | -794,530 (-12.52%) | Filing History |
| 2024-07-10 10:10 am Sale | 2024-07-09 | 13G | Edgewise Therapeutics, Inc. EWTX | FMR LLC | 4,780,562 5.118% | -1,711,951 (-26.37%) | Filing History |